$354.670
-10.853 (-3.06%)Zum Schluss
Umsatzquellen von JLL
Jones Lang LaSalle Incorporated (JLL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Workplace management, accounting for 53.5% of total sales, equivalent to $3.71B. Other significant revenue streams include Project management and Investment Sales, Debt/Equity Advisory and Other. Understanding this composition is critical for investors evaluating how JLL navigates market cycles within the Real Estate Services industry.
Profitabilität und Margen von JLL
Evaluating the bottom line, Jones Lang LaSalle Incorporated maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.59%, while the net margin is 3.09%. These profitability ratios, combined with a Return on Equity (ROE) of 13.78%, provide a clear picture of how effectively JLL converts its operational activities into shareholder value.
JLL im Vergleich zur Peergroup
In the context of the broader market, JLL competes directly with industry leaders such as FSV and MRP. With a market capitalization of $17.25B, it holds a leading position in the sector. When comparing efficiency, JLL's gross margin of N/A stands against FSV's 29.68% and MRP's 100.00%. Such benchmarking helps identify whether Jones Lang LaSalle Incorporated is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Jones Lang LaSalle Inc
Jones Lang LaSalle has shown robust revenue growth, with Q2 2026 revenue at $6.93 billion, up from $6.38 billion in Q1 2026. The net income for Q2 2026 was $215.6 million, reflecting a solid year-over-year growth trajectory. The company has also demonstrated improving net margins, reaching 3.09% in Q2 2026, up from 2.50% in Q1 2026.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.